Cancer immunotherapy

Product description

Triskelion b.v. Offers a wide range of products which includes cancer immunotherapy. Features: it is recognized by the immune system, whereby costimulatory receptors expressed on t cells have proven to potently amplify anti-tumor immunity. This approach is extremely successful in treating cancer patients, applying the immune checkpoint inhibitors (ici) pd-1 and ctla-4. Contact us for more information.
Read more


Categories Analysis
Sales markets Western Europe; Eastern Europe
Origin Netherlands
Selling Points Energy & Endurance; Immune Health; Product Features
Show more specifications

More products from TRISKELION B.V.

View all our products (16)

Products from other suppliers

Cancer immunotherapy

Contact information




View all contact information